Involvement	O
of	O
transcription	B-protein
factor	I-protein
YB-1	B-protein
in	O
human	O
T-cell	O
lymphotropic	O
virus	O
type	O
I	O
basal	O
gene	O
expression	O
.	O

Sequences	O
which	O
control	O
basal	O
human	O
T-cell	O
lymphotropic	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
transcription	O
likely	O
play	O
an	O
important	O
role	O
in	O
initiation	O
and	O
maintenance	O
of	O
virus	O
replication	O
.	O

We	O
previously	O
identified	O
and	O
analyzed	O
a	O
45-nucleotide	B-DNA
sequence	I-DNA
(	O
downstream	B-DNA
regulatory	I-DNA
element	I-DNA
1	I-DNA
[	O
DRE	B-DNA
1	I-DNA
]	O
)	O
,	O
+195	B-DNA
to	I-DNA
+240	I-DNA
,	O
at	O
the	O
boundary	O
of	O
the	O
R/U5	B-DNA
region	I-DNA
of	O
the	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
which	O
is	O
required	O
for	O
HTLV-I	O
basal	O
transcription	O
.	O

We	O
identified	O
a	O
protein	O
,	O
p37	O
,	O
which	O
specifically	O
bound	O
to	O
DRE	B-DNA
1	I-DNA
.	O

An	O
affinity	O
column	O
fraction	O
,	O
containing	O
p37	B-protein
,	O
stimulated	O
HTLV-I	O
transcription	O
approximately	O
12-fold	O
in	O
vitro	O
.	O

We	O
now	O
report	O
the	O
identification	O
of	O
a	O
cDNA	B-DNA
clone	I-DNA
(	O
15B-7	B-DNA
)	O
,	O
from	O
a	O
Jurkat	B-DNA
expression	I-DNA
library	I-DNA
,	O
that	O
binds	O
specifically	O
to	O
the	O
DRE	B-DNA
1	I-DNA
regulatory	I-DNA
sequence	I-DNA
.	O

Binding	O
of	O
the	O
cDNA	B-protein
fusion	I-protein
protein	I-protein
,	O
similarly	O
to	O
the	O
results	O
obtained	O
with	O
purified	O
Jurkat	O
protein	O
,	O
was	O
decreased	O
by	O
introduction	O
of	O
site-specific	O
mutations	O
in	O
the	O
DRE	B-DNA
1	I-DNA
regulatory	I-DNA
sequence	I-DNA
.	O

In	O
vitro	O
transcription	O
and	O
translation	O
of	O
15B-7	B-DNA
cDNA	I-DNA
produced	O
a	O
fusion	B-protein
protein	I-protein
which	O
bound	O
specifically	O
to	O
the	O
HTLV-I	O
+195	O
to	O
+240	O
oligonucleotide	O
.	O

The	O
partial	B-DNA
cDNA	I-DNA
encodes	O
a	O
protein	O
which	O
is	O
homologous	O
to	O
the	O
C-terminal	B-protein
196	I-protein
amino	I-protein
acids	I-protein
of	O
the	O
36-kDa	B-protein
transcription	I-protein
factor	I-protein
,	O
YB-1	B-protein
.	O

Cotransfection	O
of	O
a	O
YB-1	B-DNA
expression	I-DNA
plasmid	I-DNA
increases	O
HTLV-I	O
basal	O
transcription	O
approximately	O
14-fold	O
in	O
Jurkat	B-cell_line
T	I-cell_line
lymphocytes	I-cell_line
.	O

On	O
the	O
basis	O
of	O
the	O
molecular	O
weight	O
,	O
DNA-binding	O
characteristics	O
,	O
and	O
in	O
vivo	O
transactivation	O
activity	O
,	O
we	O
suggest	O
that	O
the	O
previously	O
identified	O
DRE	B-DNA
1	I-DNA
-binding	O
protein	O
,	O
p37	B-protein
,	O
is	O
YB-1	B-protein
.	O

JournaL	NULL
or	NULL
VirotOGY	NULL
,	NULL
Jan.	NULL
1994	NULL
,	NULL
p.	NULL
561-565	NULL
0022-538	NULL
X/94/	NULL
$	NULL
04.00	NULL
+0	NULL
Copyright	NULL
Â©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

68	NULL
,	NULL
No	NULL
.	NULL

1	NULL
Involvement	NULL
of	NULL
Transcription	NULL
Factor	NULL
YB-1	NULL
in	NULL
Human	NULL
T-Cell	NULL
Lymphotropic	NULL
Virus	NULL
Type	NULL
I	NULL
Basal	NULL
Gene	NULL
Expression	NULL
FATAH	NULL
KASHANCHI	NULL
,	NULL
JANET	NULL
F.	NULL
DUVALL	NULL
,	NULL
JURGEN	NULL
DITTMER	NULL
,	NULL
ALIDAD	NULL
MIRESKANDARLI	NULL
,	NULL
ROBERT	NULL
L.	NULL
REID	NULL
,	NULL
SCOTT	NULL
D.	NULL
GITLIN	NULL
,	NULL
anp	NULL
JOHN	NULL
N.	NULL
BRADY*	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
Received	NULL
12	NULL
August	NULL
1993/Accepted	NULL
19	NULL
October	NULL
1993	NULL
Sequences	NULL
which	NULL
control	NULL
basal	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcription	NULL
likely	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
initiation	NULL
and	NULL
maintenance	NULL
of	NULL
virus	NULL
replication	NULL
.	NULL

We	NULL
previously	NULL
identified	NULL
and	NULL
analyzed	NULL
a	NULL
45-nucleotide	NULL
sequence	NULL
(	NULL
downstream	NULL
regulatory	NULL
element	NULL
1	NULL
[	NULL
DRE	NULL
1	NULL
]	NULL
)	NULL
,	NULL
+195	NULL
to	NULL
+240	NULL
,	NULL
at	NULL
the	NULL
boundary	NULL
of	NULL
the	NULL
R/US5	NULL
region	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
which	NULL
is	NULL
required	NULL
for	NULL
HTLV-I	NULL
basal	NULL
transcription	NULL
.	NULL

We	NULL
identified	NULL
a	NULL
protein	NULL
,	NULL
p37	NULL
,	NULL
which	NULL
specifically	NULL
bound	NULL
to	NULL
DRE	NULL
1	NULL
.	NULL

An	NULL
affinity	NULL
column	NULL
fraction	NULL
,	NULL
containing	NULL
p37	NULL
,	NULL
stimulated	NULL
HTLV-I	NULL
transcription	NULL
approximately	NULL
12-fold	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
(	NULL
15B-7	NULL
)	NULL
,	NULL
from	NULL
a	NULL
Jurkat	NULL
expression	NULL
library	NULL
,	NULL
that	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
DRE	NULL
1	NULL
regulatory	NULL
sequence	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
cDNA	NULL
fusion	NULL
protein	NULL
,	NULL
similarly	NULL
to	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
purified	NULL
Jurkat	NULL
protein	NULL
,	NULL
was	NULL
decreased	NULL
by	NULL
introduction	NULL
of	NULL
site-specific	NULL
mutations	NULL
in	NULL
the	NULL
DRE	NULL
1	NULL
regulatory	NULL
sequence	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
15B-7	NULL
cDNA	NULL
produced	NULL
a	NULL
fusion	NULL
protein	NULL
which	NULL
bound	NULL
specifically	NULL
to	NULL
the	NULL
HTLV-I	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
.	NULL

The	NULL
partial	NULL
cDNA	NULL
encodes	NULL
a	NULL
protein	NULL
which	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
C-terminal	NULL
196	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
36-kDa	NULL
transcription	NULL
factor	NULL
,	NULL
YB-1	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
YB-1	NULL
expression	NULL
plasmid	NULL
increases	NULL
HTLV-I	NULL
basal	NULL
transcription	NULL
approximately	NULL
14-fold	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
molecular	NULL
weight	NULL
,	NULL
DNA-binding	NULL
characteristics	NULL
,	NULL
and	NULL
in	NULL
vivo	NULL
transactivation	NULL
activity	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
previously	NULL
identified	NULL
DRE	NULL
1-binding	NULL
protein	NULL
,	NULL
p37	NULL
,	NULL
is	NULL
YB-1	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
clinically	NULL
aggressive	NULL
form	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
the	NULL
degenerative	NULL
neuromuscular	NULL
disease	NULL
tropical	NULL
spastic	NULL
paraparesis/HTLV-I-associated	NULL
myelopathy	NULL
.	NULL

HTLV-I	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
levels	NULL
by	NULL
viral	NULL
gene	NULL
products	NULL
Tax	NULL
,	NULL
(	NULL
p40**	NULL
)	NULL
and	NULL
Rex	NULL
,	NULL
(	NULL
p27	NULL
)	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
U3	NULL
region	NULL
of	NULL
the	NULL
HTLV-I	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
contains	NULL
several	NULL
important	NULL
elements	NULL
needed	NULL
for	NULL
Tax	NULL
,	NULL
;	NULL
transactivation	NULL
.	NULL

The	NULL
21-bp	NULL
repeat	NULL
elements	NULL
(	NULL
Tax	NULL
,	NULL
-responsive	NULL
element	NULL
1	NULL
[	NULL
TRE-1	NULL
]	NULL
)	NULL
confer	NULL
Tax	NULL
;	NULL
responsiveness	NULL
to	NULL
the	NULL
HTLV-I	NULL
and	NULL
heterologous	NULL
promoters	NULL
,	NULL
function	NULL
in	NULL
either	NULL
orientation	NULL
,	NULL
and	NULL
interact	NULL
with	NULL
Tax	NULL
,	NULL
indirectly	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
34	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
,	NULL
-responsive	NULL
element	NULL
2	NULL
(	NULL
TRE-2	NULL
)	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
Ets1	NULL
,	NULL
Myb	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
TIF-1	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
12	NULL
,	NULL
23	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Sequences	NULL
downstream	NULL
of	NULL
the	NULL
RNA	NULL
initiation	NULL
site	NULL
,	NULL
encompassing	NULL
the	NULL
R	NULL
region	NULL
and	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
US	NULL
region	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
basal	NULL
gene	NULL
expression	NULL
(	NULL
17	NULL
,	NULL
22	NULL
,	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Nakamura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
reported	NULL
that	NULL
sequences	NULL
from	NULL
+104	NULL
to	NULL
+240	NULL
were	NULL
important	NULL
for	NULL
HTLV-I	NULL
basal	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
report	NULL
,	NULL
Seiki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
reported	NULL
that	NULL
sequences	NULL
between	NULL
+32	NULL
and	NULL
+266	NULL
were	NULL
important	NULL
for	NULL
HTLV-I	NULL
basal	NULL
mRNA	NULL
synthesis	NULL
.	NULL

The	NULL
downstream	NULL
element	NULL
was	NULL
orientation	NULL
independent	NULL
but	NULL
was	NULL
effective	NULL
only	NULL
when	NULL
it	NULL
was	NULL
located	NULL
between	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
.	NULL

The	NULL
downstream	NULL
element	NULL
was	NULL
not	NULL
Tax	NULL
;	NULL
responsive	NULL
.	NULL

A	NULL
distinct	NULL
regulatory	NULL
element	NULL
(	NULL
33	NULL
)	NULL
,	NULL
which	NULL
may	NULL
function	NULL
as	NULL
an	NULL
RNA	NULL
element	NULL
,	NULL
is	NULL
located	NULL
between	NULL
+266	NULL
and	NULL
+347	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
sequences	NULL
from	NULL
+195	NULL
to	NULL
+240	NULL
(	NULL
downstream	NULL
regulatory	NULL
element	NULL
1	NULL
[	NULL
DRE	NULL
1	NULL
]	NULL
)	NULL
downstream	NULL
of	NULL
the	NULL
start	NULL
site	NULL
at	NULL
the	NULL
R/US	NULL
region	NULL
are	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Building	NULL
41	NULL
,	NULL
Room	NULL
B403	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-6201	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-4951	NULL
.	NULL

561	NULL
important	NULL
for	NULL
basal	NULL
transcription	NULL
.	NULL

A	NULL
cellular	NULL
protein	NULL
of	NULL
37	NULL
kDa	NULL
was	NULL
responsible	NULL
for	NULL
specific	NULL
binding	NULL
to	NULL
this	NULL
region	NULL
and	NULL
transac-tivating	NULL
the	NULL
promoter	NULL
(	NULL
17	NULL
)	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
cloning	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
which	NULL
binds	NULL
and	NULL
transactivates	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
through	NULL
the	NULL
DRE	NULL
1	NULL
regulatory	NULL
sequence	NULL
.	NULL

A	NULL
lambda	NULL
gt11	NULL
Jurkat	NULL
cDNA	NULL
expression	NULL
library	NULL
was	NULL
screened	NULL
to	NULL
isolate	NULL
proteins	NULL
which	NULL
specifically	NULL
interacted	NULL
with	NULL
a	NULL
*Â°P-labeled	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

The	NULL
cDNA	NULL
library	NULL
was	NULL
plated	NULL
at	NULL
10Â°	NULL
PFU	NULL
on	NULL
Escherichia	NULL
coli	NULL
YÂ¥1090	NULL
and	NULL
induced	NULL
with	NULL
10	NULL
mM	NULL
IPTG	NULL
(	NULL
isopropylthiogalactoside	NULL
)	NULL
-soaked	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

Nitrocellulose	NULL
filters	NULL
were	NULL
denatured	NULL
and	NULL
renatured	NULL
with	NULL
guanidinium	NULL
hydrochloride	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
39	NULL
)	NULL
.	NULL

For	NULL
screening	NULL
,	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
TNE	NULL
200	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
200	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4Â°C	NULL
and	NULL
subsequently	NULL
incubated	NULL
with	NULL
approximately	NULL
5	NULL
x	NULL
10Â°	NULL
cpm	NULL
of	NULL
P-radiolabeled	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
probe	NULL
per	NULL
ml	NULL
(	NULL
10Â°	NULL
cpm/pmo	NULL
!	NULL

l	NULL
)	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4Â°C	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
TNE	NULL
200	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
four	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
recombinant	NULL
lambda	NULL
phage	NULL
which	NULL
expressed	NULL
a	NULL
fusion	NULL
protein	NULL
capable	NULL
of	NULL
specifically	NULL
binding	NULL
to	NULL
the	NULL
HTLV-I	NULL
downstream	NULL
regulatory	NULL
sequences	NULL
.	NULL

The	NULL
wild-type	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
a	NULL
five-base-substitution	NULL
mutant	NULL
(	NULL
17	NULL
)	NULL
,	NULL
specifically	NULL
bound	NULL
to	NULL
recombinant	NULL
clone	NULL
15B-7	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
five-base-substitution	NULL
mutant	NULL
of	NULL
oligonucleotide	NULL
+195	NULL
to	NULL
+240	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
decrease	NULL
binding	NULL
of	NULL
the	NULL
Jurkat	NULL
DRE	NULL
1-binding	NULL
protein	NULL
,	NULL
p37	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Recombinant	NULL
phage	NULL
clone	NULL
15B-7	NULL
was	NULL
subsequently	NULL
se-quenced	NULL
,	NULL
by	NULL
using	NULL
multiple	NULL
overlapping	NULL
primers	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Computer	NULL
analysis	NULL
of	NULL
the	NULL
15B-7	NULL
amino	NULL
acid	NULL
sequence	NULL
demonstrated	NULL
greater	NULL
than	NULL
99	NULL
%	NULL
homology	NULL
,	NULL
over	NULL
a	NULL
196-amino-acid	NULL
stretch	NULL
,	NULL
to	NULL
the	NULL
C-terminal	NULL
domain	NULL
of	NULL
a	NULL
previously	NULL
identified	NULL
transcription	NULL
factor	NULL
,	NULL
YB-1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
36-kDa	NULL
protein	NULL
binds	NULL
562	NULL
NOTES	NULL
o	NULL
)	NULL
ooc	NULL
YB-1	NULL
MSSEAETOQP	NULL
PAAPPAAPAL	NULL
SAADTKPGTT	NULL
++	NULL
vn	NULL
669	NULL
Gsc	NULL
DbpA	NULL
MSEAGEATTT	NULL
TTTTLPQAPT	NULL
EAAAAAPQDP	NULL
APKSPVGSGA	NULL
PQAAAPAPAA	NULL
1Â§B-7	NULL
|	NULL
Â«	NULL
+666	NULL
Â«	NULL
kk	NULL
k	NULL
%	NULL
kkk	NULL
kk	NULL
kkk	NULL
64	NULL
kak	NULL
kkk	NULL
a	NULL
aaa	NULL
aa	NULL
aa	NULL
ee	NULL
ea	NULL
ak	NULL
a	NULL
afr	NULL
rll	NULL
s	NULL
YB-1	NULL
AGSGGPGGLT	NULL
ttt	NULL
nnn	NULL
nn	NULL
nnn	NULL
ns	NULL
SAAPA	NULL
GGDKKVIATK	NULL
VLETVKWFNV	NULL
DbpA	NULL
HVAGNPGGDA	NULL
APAATGTAAA	NULL
ASLAAAAGSE	NULL
DAEKKVLATK	NULL
VLGTVKWENV	NULL
100	NULL
149	NULL
1Â§B-7	NULL
+666	NULL
t	NULL
6	NULL
6	NULL
6	NULL
6	NULL
Â«	NULL
Â«	NULL
6	NULL
a	NULL
t	NULL
a	NULL
t	NULL
66+	NULL
nk	NULL
kd	NULL
eee	NULL
ee	NULL
ae	NULL
SVGDGET	NULL
VEFDVVEGEX	NULL
YB-1	NULL
RNGYGFINRN	NULL
DTKEDVFVHQ	NULL
TAIKKNNPRK	NULL
YLRSVGDGET	NULL
VEFDVVEGEK	NULL
DbpA	NULL
RNGYGFINRN	NULL
DTKEDVFVHQ_	NULL
TALKKNNPRK	NULL
YLRSVGDGET	NULL
VEFDVVEGEK	NULL
150	NULL
199	NULL
15B-7	NULL
QEAANVTGPI	NULL
GGVPVOGSKY	NULL
AADRNHYRR+	NULL
+YPRRRGPPR	NULL
NYOONYQNSE	NULL
YB-1	NULL
GEEAANVTGP	NULL
:	NULL
GGVPVOGSKY	NULL
AADRNHYRR	NULL
Â»	NULL
+YPRRRGPPR	NULL
NYQQNYQNSE	NULL
DbpA	NULL
GAEAANVTGP	NULL
]	NULL
DGVPVEGSRY	NULL
AADRRRYRRG	NULL
YYGRRRGPPR	NULL
NYAGEEEEEG	NULL
Â»	NULL
+~+_	NULL
71	NULL
â	NULL
+3	NULL
Eââ	NULL
200	NULL
249	NULL
15B-7	NULL
SGEKNEGSES	NULL
+t	NULL
<	NULL
>	NULL
AQORR	NULL
PYRRRRFPPY	NULL
YMRRPYGRRP	NULL
YB-1	NULL
SGEKNEGSES	NULL
,	NULL
APEGQÂ®	NULL
+++	NULL
++	NULL
>	NULL
>	NULL
>	NULL
AQQRR	NULL
PYRRRRFPPY	NULL
YMRRPYGRRP	NULL
DbpA	NULL
--	NULL
SGSSEGFDPP	NULL
ATDROFSCAR	NULL
NQLRRPQYRP	NULL
QYRQRRFPPY	NULL
HVGQTFDRRS	NULL
--	NULL
==	NULL
250	NULL
299	NULL
15B-7	NULL
|_	NULL
QYSNPPVQ-G	NULL
EVMEGADNQG	NULL
AGR	NULL
++QGRP	NULL
VRQN+	NULL
NYR	NULL
CYRPRFRRGP	NULL
YB-1	NULL
QYSNPPVQG	NULL
EVMEGADNQG	NULL
VROQN+	NULL
>	NULL
MYR	NULL
GYRPRFRRGP	NULL
DbpA	NULL
-_	NULL
RVLPHPNRÂ®I	NULL
QAGEIGEMKD	NULL
CVP	NULL
EGAQL	NULL
QGPVHRNPTY	NULL
RPRYRSRGPP	NULL
oe	NULL
3	NULL
+-	NULL
t	NULL
+o	NULL
30Â¢	NULL
C	NULL
a	NULL
349	NULL
15B-7	NULL
__	NULL
PRQROPREDG	NULL
NEEDKENQGD	NULL
ETOGQ-OPPQ	NULL
R	NULL
>	NULL
RYRRNPNY	NULL
RRRRPENPKP	NULL
vB-L	NULL
__	NULL
PROROPREDG	NULL
NEEDKENQGD	NULL
ETQCQ	NULL
QPPQ	NULL
RRRRPENPKP	NULL
DbpA	NULL
RPRPAP+AVG	NULL
EAEDKENQOQA	NULL
RRGYRRPYNY	NULL
RRRPPSS***	NULL
+++	NULL
]	NULL
[	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
]	NULL
[	NULL
+	NULL
+04	NULL
+	NULL
+	NULL
+	NULL
+	NULL
]	NULL
350	NULL
370	NULL
15B-7	NULL
_-	NULL
QD-CKETKAA	NULL
DPPAENSRSR	NULL
G	NULL
YÂ¥B-L	NULL
--	NULL
QD-GXETKAA	NULL
DppaENSRSR	NULL
G	NULL
DbpA	NULL
wee	NULL
te	NULL
te	NULL
de	NULL
e	NULL
de	NULL
w	NULL
e	NULL
dea	NULL
ac	NULL
Â®	NULL
%	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
lambda	NULL
gt11	NULL
cDNA	NULL
clone	NULL
15B-7	NULL
and	NULL
comparison	NULL
with	NULL
human	NULL
YB-1	NULL
and	NULL
human	NULL
DNA-binding	NULL
protein	NULL
A	NULL
(	NULL
38	NULL
)	NULL
.	NULL

A	NULL
single	NULL
positive	NULL
plaque	NULL
was	NULL
aspirated	NULL
into	NULL
a	NULL
tube	NULL
containing	NULL
lambda	NULL
gt11	NULL
primers	NULL
1218	NULL
and	NULL
1222	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
and	NULL
PCR	NULL
amplified	NULL
,	NULL
and	NULL
the	NULL
cDNA	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pCRII	NULL
plasmid	NULL
(	NULL
Invitrogen	NULL
)	NULL
for	NULL
both	NULL
DNA	NULL
sequencing	NULL
and	NULL
DNA	NULL
expression	NULL
.	NULL

The	NULL
15B-7	NULL
amino	NULL
acid	NULL
sequence	NULL
was	NULL
homologous	NULL
to	NULL
the	NULL
C-terminal	NULL
196	NULL
amino	NULL
acids	NULL
of	NULL
YB-1	NULL
,	NULL
except	NULL
for	NULL
glutamic	NULL
acid	NULL
at	NULL
position	NULL
151	NULL
,	NULL
which	NULL
was	NULL
replaced	NULL
with	NULL
alanine	NULL
.	NULL

Interesting	NULL
features	NULL
including	NULL
a	NULL
conserved	NULL
C-terminal	NULL
box	NULL
(	NULL
CI	NULL
)	NULL
,	NULL
a	NULL
protamine-like	NULL
domain	NULL
(	NULL
[	NULL
+	NULL
]	NULL
)	NULL
,	NULL
and	NULL
an	NULL
acidic	NULL
amino	NULL
acid	NULL
domain	NULL
(	NULL
[	NULL
<	NULL
3	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

specifically	NULL
and	NULL
transactivates	NULL
the	NULL
Y-box	NULL
sequence	NULL
containing	NULL
an	NULL
inverted	NULL
CCAAT	NULL
box	NULL
(	NULL
8	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
YB-1	NULL
was	NULL
able	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
we	NULL
obtained	NULL
a	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
containing	NULL
YB-1	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
B.	NULL
D.	NULL
Schwartz	NULL
)	NULL
.	NULL

The	NULL
YB-1	NULL
expression	NULL
plasmid	NULL
was	NULL
transfected	NULL
along	NULL
with	NULL
HTLV-I	NULL
wild-type	NULL
or	NULL
mutant	NULL
reporter	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
plasmids	NULL
into	NULL
Jurkat	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

Results	NULL
of	NULL
such	NULL
an	NULL
experiment	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
+246	NULL
HTLV-I	NULL
promoter	NULL
CAT	NULL
plasmid	NULL
with	NULL
Tax	NULL
,	NULL
led	NULL
to	NULL
a	NULL
32Z-fold	NULL
increase	NULL
in	NULL
CAT	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
cotransfection	NULL
of	NULL
the	NULL
YB-1	NULL
expression	NULL
plasmid	NULL
,	NULL
in	NULL
increasing	NULL
amounts	NULL
,	NULL
led	NULL
to	NULL
a	NULL
maximal	NULL
stimulation	NULL
of	NULL
approximately	NULL
14-fold	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
)	NULL
.	NULL

An	NULL
apparent	NULL
squelching	NULL
effect	NULL
was	NULL
observed	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
input	NULL
YB-1	NULL
.	NULL

The	NULL
YB-1	NULL
transactivation	NULL
is	NULL
not	NULL
seen	NULL
with	NULL
plasmids	NULL
that	NULL
do	NULL
not	NULL
contain	NULL
downstream	NULL
sequences	NULL
beyond	NULL
+202	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
15	NULL
)	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
the	NULL
binding	NULL
of	NULL
YB-1	NULL
to	NULL
the	NULL
sequence	NULL
+195	NULL
to	NULL
+240	NULL
in	NULL
a	NULL
band	NULL
shift	NULL
assay	NULL
.	NULL

Figure	NULL
2B	NULL
shows	NULL
the	NULL
result	NULL
of	NULL
such	NULL
an	NULL
experiment	NULL
;	NULL
specific	NULL
binding	NULL
is	NULL
seen	NULL
with	NULL
an	NULL
extract	NULL
that	NULL
J.	NULL
Viror	NULL
.	NULL

YB-1	NULL
=-	NULL
s-	NULL
mom	NULL
sill	NULL
g	NULL
&	NULL
_	NULL
TAX	NULL
ite	NULL
n	NULL
at	NULL
<	NULL
oe	NULL
op	NULL
ime	NULL
sm	NULL
<	NULL
<	NULL
-o	NULL
Gp	NULL
en	NULL
se	NULL
>	NULL
pds	NULL
+	NULL
246	NULL
Fook	NULL
$	NULL
$	NULL
$	NULL
&	NULL
o-	NULL
-o	NULL
_-	NULL
-	NULL
_-	NULL
-	NULL
-	NULL
_-	NULL
pds	NULL
+	NULL
202	NULL
Eich	NULL
dhe	NULL
L	NULL
e	NULL
e	NULL
Actitis	NULL
pds	NULL
+	NULL
157	NULL
zo	NULL
LJR	NULL
LL	NULL
GRDEILKITL	NULL
-	NULL
op	NULL
pop	NULL
$	NULL
#	NULL
C	NULL
@	NULL
6	NULL
&	NULL
â¬	NULL
Â®	NULL
Cp	NULL
#	NULL
@	NULL
~	NULL
@	NULL
@	NULL
@	NULL
-0	NULL
@	NULL
02000006	NULL
1Â°2	NULL
3	NULL
%	NULL
45	NULL
e	NULL
``	NULL
Zis	NULL
g	NULL
40Â°11	NULL
12	NULL
48	NULL
14	NULL
15	NULL
%	NULL
Conversion	NULL
2.89	NULL
96.6	NULL
2.75	NULL
40.7	NULL
15.7	NULL
1.03	NULL
95.5	NULL
1.34	NULL
1.51	NULL
1.79	NULL
1.15	NULL
68.6	NULL
1.23	NULL
1.36	NULL
1.10	NULL
pCRIWYB-1	NULL
Ext	NULL
Â£Â°+	NULL
[	NULL
4Â°	NULL
``	NULL
~	NULL
pCR	NULL
IVI5B7	NULL
Ext	NULL
.	NULL

-+	NULL
++	NULL
pCRII	NULL
Ext	NULL
F	NULL
ak	NULL
Mutant	NULL
Comp	NULL
.	NULL

-	NULL
-	NULL
-	NULL
+	NULL
NonspecificComp	NULL
.	NULL

-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
Specific	NULL
Comp	NULL
.	NULL

-	NULL
-	NULL
+	NULL
Specific	NULL
Comp	NULL
.	NULL

-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
Probe	NULL
(	NULL
HTLV-I	NULL
+195	NULL
t0	NULL
+240	NULL
)	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Probe	NULL
U2	NULL
y	NULL
aw	NULL
4	NULL
+195	NULL
to	NULL
+240	NULL
)	NULL
-+	NULL
Â®	NULL
%	NULL
-	NULL
>	NULL
W	NULL
a	NULL
g-0-in	NULL
@	NULL
an	NULL
an	NULL
ag	NULL
)	NULL
\/	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1.2	NULL
3.46	NULL
6	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

CAT	NULL
assay	NULL
and	NULL
gel	NULL
shift	NULL
pattern	NULL
of	NULL
YB-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
HTLV-I	NULL
+195	NULL
to	NULL
+240	NULL
element	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
reporter	NULL
HTLV-I	NULL
promoter	NULL
plasmid	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
pds+157	NULL
,	NULL
pds+202	NULL
,	NULL
or	NULL
pds+246	NULL
)	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
the	NULL
YÂ¥B-1	NULL
expression	NULL
plasmid	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
mobility	NULL
band	NULL
shift	NULL
assay	NULL
of	NULL
in	NULL
vitro-translated	NULL
YB-1	NULL
on	NULL
the	NULL
HTLV-I	NULL
DRE	NULL
1	NULL
sequence	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

The	NULL
rabbit	NULL
reticulocyte	NULL
TNT	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
used	NULL
to	NULL
translate	NULL
the	NULL
recombinant	NULL
15B-7	NULL
cDNA	NULL
clone	NULL
isolated	NULL
from	NULL
the	NULL
lambda	NULL
gtt1	NULL
library	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
1	NULL
wl	NULL
of	NULL
a	NULL
1:5	NULL
dilution	NULL
of	NULL
TNT	NULL
extract	NULL
(	NULL
Ext	NULL
.	NULL
)	NULL

containing	NULL
the	NULL
15B-7	NULL
clone	NULL
and	NULL
6	NULL
ng	NULL
of	NULL
the	NULL
DRE	NULL
1	NULL
+195	NULL
to	NULL
+240	NULL
**P-end-labeled	NULL
probe	NULL
.	NULL

The	NULL
gel	NULL
shift	NULL
complex	NULL
(	NULL
arrow	NULL
)	NULL
is	NULL
inhibited	NULL
by	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
same	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
spanning	NULL
-38	NULL
to	NULL
-8	NULL
of	NULL
the	NULL
HIV	NULL
promoter	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
bands	NULL
are	NULL
not	NULL
seen	NULL
with	NULL
a	NULL
TNT	NULL
extract	NULL
without	NULL
the	NULL
input	NULL
15B-7	NULL
plasmid	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

Comp	NULL
.	NULL

,	NULL
competitor	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gel	NULL
shift	NULL
competition	NULL
analysis	NULL
using	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
DRE	NULL
1	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
a	NULL
DRE	NULL
1	NULL
base	NULL
substitution	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

contained	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
15B-7	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
but	NULL
not	NULL
the	NULL
in	NULL
vitro-translated	NULL
pCRII	NULL
control	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

The	NULL
consensus	NULL
Y-box	NULL
sequence	NULL
is	NULL
5-CTGATTGGCCAA-3	NULL
'	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
HTLV-I	NULL
+195	NULL
to	NULL
+240	NULL
sequence	NULL
contains	NULL
the	NULL
sequence	NULL
(	NULL
+210	NULL
to	NULL
+222	NULL
;	NULL
the	NULL
underlined	NULL
bases	NULL
differ	NULL
from	NULL
the	NULL
consensus	NULL
YB-1	NULL
sequence	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
C	NULL
demonstrate	NULL
that	NULL
the	NULL
wild-type	NULL
HTLV-I	NULL
sequence	NULL
,	NULL
but	NULL
not	NULL
a	NULL
nonspecific	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
mutant	NULL
HTLV-I	NULL
+195	NULL
to	NULL
+240	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
sequence	NULL
AA-3	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
was	NULL
capable	NULL
of	NULL
competing	NULL
for	NULL
15B-7	NULL
binding	NULL
.	NULL

As	NULL
pointed	NULL
out	NULL
above	NULL
,	NULL
the	NULL
base	NULL
substitution	NULL
mutant	NULL
of	NULL
oligonucleotide	NULL
+195	NULL
to	NULL
+240	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
decrease	NULL
binding	NULL
of	NULL
the	NULL
Jurkat	NULL
DRE	NULL
1-binding	NULL
protein	NULL
,	NULL
p37	NULL
(	NULL
17	NULL
)	NULL
.	NULL

It	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
cells	NULL
expressing	NULL
HTLV-I	NULL
regulatory	NULL
proteins	NULL
resulted	NULL
in	NULL
the	NULL
altered	NULL
expression	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
YB-1	NULL
185	NULL
-	NULL
-	NULL
Wien	NULL
um	NULL
moat	NULL
Tax	NULL
,	NULL
-	NULL
B-actin	NULL
co	NULL
&	NULL
|	NULL
12245	NULL
12.3.4	NULL
5-6	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

YB-1	NULL
RNA	NULL
analysis	NULL
of	NULL
HTLV	NULL
--	NULL
transformed	NULL
cell	NULL
lines	NULL
and	NULL
HTLV-I	NULL
Tax	NULL
,	NULL
-expressing	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNAs	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
HTLV-I-transformed	NULL
cell	NULL
lines	NULL
MT-2	NULL
,	NULL
MT-4	NULL
,	NULL
C81	NULL
,	NULL
and	NULL
Hut	NULL
102	NULL
and	NULL
from	NULL
uninfected	NULL
Jurkat	NULL
cells	NULL
Fourteen	NULL
micrograms	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1.2	NULL
%	NULL
denaturing	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
and	NULL
hybridized	NULL
under	NULL
conditions	NULL
described	NULL
elsewhere	NULL
(	NULL
9	NULL
)	NULL
.	NULL

YB-1	NULL
cDNA	NULL
was	NULL
labeled	NULL
by	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
6	NULL
x	NULL
10Â°	NULL
cpm/pg	NULL
of	NULL
DNA	NULL
by	NULL
using	NULL
the	NULL
primer	NULL
extension	NULL
reaction	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
X-ray	NULL
film	NULL
for	NULL
2	NULL
h	NULL
by	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Rehybridization	NULL
with	NULL
a	NULL
B-actin-specific	NULL
probe	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
9	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
JPX-9	NULL
and	NULL
JPX/M	NULL
cells	NULL
,	NULL
permanently	NULL
transformed	NULL
with	NULL
a	NULL
metallothionein-inducible	NULL
gene	NULL
encoding	NULL
native	NULL
or	NULL
frameshift	NULL
mutant	NULL
Tax	NULL
;	NULL
,	NULL
respectively	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
22	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
150	NULL
wM	NULL
ZnCl	NULL
,	NULL
,	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

For	NULL
hybridization	NULL
with	NULL
Tax	NULL
;	NULL
-specific	NULL
sequences	NULL
,	NULL
a	NULL
full-length	NULL
Tax	NULL
,	NULL
cDNA	NULL
probe	NULL
was	NULL
used	NULL
.	NULL

of	NULL
YB-1	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
compared	NULL
YB-1	NULL
mRNA	NULL
levels	NULL
in	NULL
the	NULL
HTLV-I-transformed	NULL
cell	NULL
lines	NULL
MT	NULL
-2	NULL
,	NULL
MT-4	NULL
,	NULL
C81	NULL
,	NULL
and	NULL
Hut	NULL
102	NULL
and	NULL
control	NULL
uninfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
was	NULL
performed	NULL
with	NULL
14	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
RNA	NULL
isolated	NULL
from	NULL
each	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
*Â°P-labeled	NULL
YB-1-specific	NULL
probe	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
data	NULL
,	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
show	NULL
similar	NULL
levels	NULL
of	NULL
the	NULL
1.5-kb	NULL
YB-1	NULL
A	NULL
yBi.-	NULL
_-	NULL
-	NULL
<	NULL
e.	NULL
D12	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Â¥	NULL
'-	NULL
&	NULL
CDI	NULL
-	NULL
0	NULL
-	NULL
o-	NULL
-o	NULL
o-	NULL
Â°	NULL
+oo+	NULL
#	NULL
TAT	NULL
=	NULL
+	NULL
je	NULL
Shale	NULL
+	NULL
@	NULL
080	NULL
@	NULL
%	NULL
e	NULL
C	NULL
#	NULL
#	NULL
S	NULL
oe	NULL
0Â°	NULL
00	NULL
0	NULL
o	NULL
e	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
%	NULL
Conversion	NULL
38	NULL
99	NULL
389	NULL
85.1	NULL
482	NULL
21	NULL
989	NULL
NOTES	NULL
563	NULL
mRNA	NULL
in	NULL
all	NULL
five	NULL
cell	NULL
lines	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
mRNA	NULL
synthesis	NULL
in	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
HTLV-I	NULL
viral	NULL
regulatory	NULL
proteins	NULL
would	NULL
not	NULL
show	NULL
continuous	NULL
elevated	NULL
expression	NULL
of	NULL
inducible	NULL
mRNAs	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
next	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
,	NULL
on	NULL
YB-1	NULL
expression	NULL
in	NULL
the	NULL
Jurkat-derived	NULL
JPX-9	NULL
cell	NULL
line	NULL
which	NULL
is	NULL
stably	NULL
transformed	NULL
with	NULL
a	NULL
metallothionein-inducible	NULL
Tax	NULL
,	NULL
gene	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
HTLV-I	NULL
proteins	NULL
that	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
viral	NULL
genome	NULL
,	NULL
Tax	NULL
,	NULL
has	NULL
been	NULL
found	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
cellular	NULL
transformation	NULL
and	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
;	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transactivate	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Upon	NULL
incubation	NULL
with	NULL
150	NULL
wM	NULL
ZnCl	NULL
,	NULL
for	NULL
22	NULL
h	NULL
,	NULL
Tax	NULL
,	NULL
;	NULL
was	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
YB-1	NULL
mRNA	NULL
levels	NULL
were	NULL
the	NULL
same	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
ZnCl	NULL
,	NULL
.	NULL

Since	NULL
the	NULL
Tax	NULL
,	NULL
produced	NULL
in	NULL
JPX-9	NULL
cells	NULL
was	NULL
functional	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
transient	NULL
transfection	NULL
using	NULL
the	NULL
Tax	NULL
,	NULL
-responsive	NULL
HTLV-I	NULL
LTR-CAT	NULL
plasmid	NULL
pU3R-CAT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
Tax	NULL
,	NULL
does	NULL
not	NULL
regulate	NULL
YB-1	NULL
expression	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
have	NULL
also	NULL
found	NULL
a	NULL
YB-1	NULL
control	NULL
element	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
LTR	NULL
.	NULL

This	NULL
sequence	NULL
,	NULL
5-CTGATTGGCAGA-3	NULL
'	NULL
,	NULL
is	NULL
present	NULL
approximately	NULL
370	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
and	NULL
has	NULL
been	NULL
previously	NULL
footprinted	NULL
and	NULL
named	NULL
site	NULL
A	NULL
(	NULL
7	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Site	NULL
A	NULL
is	NULL
present	NULL
at	NULL
the	NULL
very	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
NRE	NULL
)	NULL
,	NULL
and	NULL
its	NULL
function	NULL
is	NULL
unknown	NULL
.	NULL

All	NULL
HIV	NULL
promoters	NULL
sequenced	NULL
to	NULL
date	NULL
,	NULL
except	NULL
isolates	NULL
HIVHXB2	NULL
(	NULL
G	NULL
to	NULL
A	NULL
,	NULL
364	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
site	NULL
)	NULL
and	NULL
HIVREF	NULL
(	NULL
T	NULL
to	NULL
C	NULL
,	NULL
366	NULL
bases	NULL
upstream	NULL
of	NULL
start	NULL
site	NULL
)	NULL
,	NULL
have	NULL
the	NULL
above	NULL
wild-type	NULL
sequence	NULL
(	NULL
25	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
YB-1	NULL
on	NULL
two	NULL
HIV	NULL
promoter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
first	NULL
construct	NULL
,	NULL
CD12	NULL
,	NULL
contains	NULL
the	NULL
entire	NULL
HIV	NULL
promoter	NULL
.	NULL

The	NULL
second	NULL
construct	NULL
,	NULL
CD7	NULL
,	NULL
contains	NULL
273	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
RNA	NULL
start	NULL
site	NULL
,	NULL
deleting	NULL
the	NULL
putative	NULL
YB-1	NULL
binding	NULL
site	NULL
.	NULL

Upon	NULL
transfection	NULL
of	NULL
YB-1	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
the	NULL
HIV	NULL
LTR-CAT	NULL
plasmids	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
basal	NULL
transcription	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
the	NULL
deletion	NULL
mutant	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
,	NULL
was	NULL
observed	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
YB-1	NULL
to	NULL
transactivate	NULL
HIV	NULL
transcription	NULL
has	NULL
been	NULL
reproduced	NULL
in	NULL
several	NULL
independent	NULL
experiments	NULL
.	NULL

As	NULL
with	NULL
the	NULL
results	NULL
presented	NULL
above	NULL
,	NULL
an	NULL
apparent	NULL
squelching	NULL
effect	NULL
was	NULL
observed	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
YB-1	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

pCRI/1SB-7	NULL
Ext	NULL
-	NULL
+	NULL
+	NULL
+	NULL
=	NULL
a	NULL
Mutant	NULL
Comp	NULL
.	NULL

_-	NULL
-	NULL
-	NULL
+	NULL
gully	NULL
SpecificComp	NULL
.	NULL

-	NULL
-	NULL
+	NULL
--	NULL
-	NULL
Probe	NULL
(	NULL
HIV	NULL
)	NULL
+	NULL
+	NULL
++	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

CAT	NULL
assay	NULL
and	NULL
gel	NULL
shift	NULL
pattern	NULL
of	NULL
YB-1	NULL
on	NULL
an	NULL
upstream	NULL
HIV	NULL
promoter	NULL
element	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
reporter	NULL
plasmids	NULL
CD12	NULL
(	NULL
wild-type	NULL
LTR	NULL
;	NULL
5	NULL
ug	NULL
)	NULL
or	NULL
deletion	NULL
mutant	NULL
CD7	NULL
(	NULL
-	NULL
273	NULL
;	NULL
5	NULL
g	NULL
)	NULL
(	NULL
3	NULL
)	NULL
and	NULL
various	NULL
concentrations	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
or	NULL
10	NULL
ug	NULL
)	NULL
of	NULL
the	NULL
YB-1	NULL
expression	NULL
plasmid	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
shift	NULL
assay	NULL
using	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
15B-7	NULL
from	NULL
a	NULL
TNT	NULL
extract	NULL
(	NULL
Ext	NULL
.	NULL
)	NULL

and	NULL
an	NULL
HIV	NULL
YB-l-binding-site	NULL
oligonucleotide	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
a	NULL
1:5	NULL
dilution	NULL
of	NULL
the	NULL
TNT	NULL
extract	NULL
was	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
reactions	NULL
.	NULL

The	NULL
specific	NULL
gel	NULL
shift	NULL
complex	NULL
(	NULL
arrow	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
by	NULL
a	NULL
five-base	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

564	NULL
NOTES	NULL
We	NULL
next	NULL
analyzed	NULL
a	NULL
15-base	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
HIV	NULL
YB-1-box	NULL
homology	NULL
,	NULL
5Â¢-CCCTGATTGGCAGAA-3	NULL
'	NULL
,	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
with	NULL
in	NULL
vitro-translated	NULL
15B-7	NULL
.	NULL

Figure	NULL
4B	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
a	NULL
representative	NULL
gel	NULL
shift	NULL
experiment	NULL
.	NULL

A	NULL
specific	NULL
gel	NULL
shift	NULL
complex	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
HIV	NULL
YB-1	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
in	NULL
vitro-translated	NULL
15B-7	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
shift	NULL
complex	NULL
was	NULL
inhibited	NULL
with	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
oligonucleotide	NULL
but	NULL
not	NULL
with	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
a	NULL
five-base	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
;	NULL
mutant	NULL
oligonucleotide	NULL
5Â¢-CCCTGGCCCACAGAA-3	NULL
'	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
a	NULL
37-kDa	NULL
protein	NULL
bound	NULL
specifically	NULL
to	NULL
the	NULL
HTLV-I	NULL
DRE	NULL
1	NULL
regulatory	NULL
sequence	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
radiolabeled	NULL
DRE	NULL
1	NULL
probe	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
partial	NULL
cDNA	NULL
clone	NULL
(	NULL
15B-7	NULL
)	NULL
from	NULL
a	NULL
Jurkat	NULL
lambda	NULL
gt11	NULL
cDNA	NULL
library	NULL
which	NULL
binds	NULL
specifically	NULL
to	NULL
DRE	NULL
1	NULL
.	NULL

The	NULL
DNA-binding	NULL
properties	NULL
of	NULL
the	NULL
15B-7	NULL
protein	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
p37	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Jurkat	NULL
cDNA	NULL
clone	NULL
15B-7	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
196	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
36-kDa	NULL
transcription	NULL
factor	NULL
YB-1	NULL
.	NULL

Moreover	NULL
,	NULL
cotransfection	NULL
of	NULL
YB-1	NULL
with	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
resulted	NULL
in	NULL
a	NULL
sequence-specific	NULL
transactivation	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
similar	NULL
molecular	NULL
weight	NULL
,	NULL
DNA-binding	NULL
properties	NULL
,	NULL
and	NULL
in	NULL
vivo	NULL
transactivation	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
the	NULL
previously	NULL
identified	NULL
DRE	NULL
1	NULL
binding	NULL
protein	NULL
,	NULL
p37	NULL
,	NULL
was	NULL
YB-1	NULL
.	NULL

Several	NULL
distinct	NULL
families	NULL
of	NULL
proteins	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
Y-box	NULL
sequence	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

YB-1	NULL
family	NULL
members	NULL
have	NULL
been	NULL
found	NULL
to	NULL
be	NULL
markedly	NULL
conserved	NULL
in	NULL
sequence	NULL
throughout	NULL
evolution	NULL
from	NULL
bacteria	NULL
to	NULL
vertebrates	NULL
(	NULL
19	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Several	NULL
functions	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
YB-1	NULL
.	NULL

In	NULL
the	NULL
chicken	NULL
,	NULL
YB-1	NULL
expression	NULL
in	NULL
carly	NULL
liver	NULL
development	NULL
is	NULL
positively	NULL
associated	NULL
with	NULL
DNA	NULL
synthesis	NULL
or	NULL
cell	NULL
proliferation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
YB-1	NULL
family	NULL
members	NULL
in	NULL
Xenopus	NULL
frogs	NULL
,	NULL
FRG	NULL
Y1	NULL
and	NULL
FRG	NULL
Y2	NULL
,	NULL
have	NULL
apparent	NULL
functional	NULL
differences	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
YB-1	NULL
appears	NULL
to	NULL
have	NULL
limited	NULL
tissue	NULL
specificity	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
YB-1	NULL
mRNA	NULL
were	NULL
present	NULL
in	NULL
the	NULL
heart	NULL
,	NULL
muscle	NULL
,	NULL
liver	NULL
,	NULL
lung	NULL
,	NULL
adrenal	NULL
gland	NULL
,	NULL
and	NULL
brain	NULL
tissues	NULL
in	NULL
a	NULL
24-week-old	NULL
human	NULL
fetus	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
small	NULL
amounts	NULL
of	NULL
YB-1	NULL
mRNA	NULL
were	NULL
found	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
kidney	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
and	NULL
spleen	NULL
tissues	NULL
.	NULL

In	NULL
the	NULL
pancreas	NULL
,	NULL
bladder	NULL
,	NULL
stomach	NULL
,	NULL
and	NULL
testis	NULL
tissues	NULL
,	NULL
YB-1	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
by	NULL
Northern	NULL
hybridization	NULL
.	NULL

Sequences	NULL
similar	NULL
to	NULL
the	NULL
Y-box	NULL
element	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
transcription	NULL
factors	NULL
and	NULL
effect	NULL
expression	NULL
of	NULL
several	NULL
promoters	NULL
such	NULL
as	NULL
hsp70	NULL
(	NULL
38	NULL
)	NULL
,	NULL
thymidine	NULL
kinase	NULL
(	NULL
2	NULL
,	NULL
18	NULL
,	NULL
21	NULL
)	NULL
,	NULL
HLA-DR	NULL
beta-chain	NULL
(	NULL
8	NULL
)	NULL
,	NULL
mouse	NULL
(	NULL
2'-5	NULL
``	NULL
)	NULL
oligoadenylate	NULL
synthetase	NULL
gene	NULL
interferon	NULL
response	NULL
element	NULL
(	NULL
41	NULL
)	NULL
,	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
enhancer	NULL
(	NULL
30	NULL
,	NULL
37	NULL
)	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
LTR	NULL
(	NULL
30	NULL
)	NULL
,	NULL
human	NULL
papillomavirus	NULL
type	NULL
18	NULL
enhancer	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
multidrug	NULL
resistance	NULL
gene	NULL
promoter	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
YB-1	NULL
protein	NULL
has	NULL
a	NULL
number	NULL
of	NULL
interesting	NULL
domains	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

There	NULL
is	NULL
a	NULL
68-amino-acid	NULL
C-terminal	NULL
domain	NULL
that	NULL
is	NULL
perfectly	NULL
conserved	NULL
through	NULL
evolution	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
DNA	NULL
binding	NULL
.	NULL

This	NULL
conserved	NULL
region	NULL
is	NULL
followed	NULL
by	NULL
stretches	NULL
of	NULL
basic	NULL
amino	NULL
acids	NULL
resembling	NULL
protamine-like	NULL
domains	NULL
and	NULL
acidic	NULL
amino	NULL
acids	NULL
which	NULL
may	NULL
form	NULL
alpha-helices	NULL
.	NULL

Proteins	NULL
with	NULL
these	NULL
characteristics	NULL
have	NULL
been	NULL
postulated	NULL
to	NULL
form	NULL
bridges	NULL
between	NULL
distal	NULL
and	NULL
proximal	NULL
regulatory	NULL
elements	NULL
of	NULL
a	NULL
promoter	NULL
,	NULL
stabilizing	NULL
specific	NULL
protein-protein	NULL
interactions	NULL
by	NULL
bringing	NULL
two	NULL
regions	NULL
of	NULL
the	NULL
same	NULL
DNA	NULL
helix	NULL
into	NULL
juxtaposition	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Charge	NULL
clusters	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
multiprotein	NULL
complexes	NULL
.	NULL

Multiple	NULL
charge	NULL
clusters	NULL
within	NULL
one	NULL
protein	NULL
might	NULL
contribute	NULL
to	NULL
cooperative	NULL
protein-protein	NULL
and	NULL
protein-nucleic	NULL
acid	NULL
interactions	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
acidic	NULL
and	NULL
basic	NULL
domains	NULL
also	NULL
contain	NULL
six	NULL
putative	NULL
nuclear	NULL
localization	NULL
signals	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
YB-1	NULL
in	NULL
the	NULL
HTLV-I	NULL
or	NULL
HIV	NULL
viral	NULL
replication	NULL
cycle	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

Interestingly	NULL
,	NULL
there	NULL
seems	NULL
to	NULL
be	NULL
increased	NULL
expression	NULL
of	NULL
YB-1	NULL
in	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
-induced	NULL
T	NULL
J.	NULL
ViroL	NULL
.	NULL

cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Helper	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
by	NULL
IL-2	NULL
showed	NULL
expression	NULL
of	NULL
several	NULL
different	NULL
mRNAs	NULL
including	NULL
YB-1	NULL
.	NULL

Since	NULL
IL-2	NULL
is	NULL
thought	NULL
to	NULL
push	NULL
cells	NULL
from	NULL
G	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
,	NULL
it	NULL
is	NULL
speculated	NULL
that	NULL
YB-1	NULL
is	NULL
involved	NULL
in	NULL
growth-associated	NULL
gene	NULL
expression	NULL
including	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
see	NULL
whether	NULL
IL-2-induced	NULL
genes	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
YB-1	NULL
)	NULL
can	NULL
stimulate	NULL
latent	NULL
viral	NULL
gene	NULL
expression	NULL
and	NULL
result	NULL
in	NULL
active	NULL
viral	NULL
replication	NULL
.	NULL

Finally	NULL
,	NULL
since	NULL
YB-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
multigene	NULL
family	NULL
of	NULL
related	NULL
genes	NULL
,	NULL
the	NULL
potential	NULL
for	NULL
differential	NULL
regulation	NULL
by	NULL
the	NULL
distinct	NULL
family	NULL
members	NULL
exists	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ahmed	NULL
,	NULL
Y.	NULL
F.	NULL
,	NULL
G.	NULL
M.	NULL
Gilmartin	NULL
,	NULL
S.	NULL
M.	NULL
Hanly	NULL
,	NULL
J.	NULL
R.	NULL
Nevins	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
HTLV-I	NULL
Rex	NULL
response	NULL
element	NULL
mediates	NULL
a	NULL
novel	NULL
form	NULL
of	NULL
mRNA	NULL
polyadenylation	NULL
.	NULL

Cell	NULL
64:727-737	NULL
.	NULL

2	NULL
.	NULL

Arcot	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
E.	NULL
K.	NULL
Flemington	NULL
,	NULL
and	NULL
P.	NULL
L.	NULL
Deininger	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
human	NULL
thymidine	NULL
kinase	NULL
gene	NULL
promoter	NULL
.	NULL

Deletion	NULL
analysis	NULL
and	NULL
specific	NULL
protein	NULL
binding	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:2343-2349	NULL
.	NULL

3	NULL
.	NULL

Bohan	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
F.	NULL
Kashanchi	NULL
,	NULL
B.	NULL
Ensoli	NULL
,	NULL
L.	NULL
Buonaguro	NULL
,	NULL
K.	NULL
Boris-Lawrie	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
Tat	NULL
transactivation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
vifro	NULL
.	NULL

Gene	NULL
Exp	NULL
.	NULL

2:391-407	NULL
.	NULL

4	NULL
.	NULL

Bosselut	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
M.	NULL
Bailly	NULL
,	NULL
A.	NULL
Hemar	NULL
,	NULL
J.	NULL
N.	NULL
Brady	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
c-ets-1	NULL
protoon-cogene	NULL
and	NULL
the	NULL
related	NULL
Ets2	NULL
protein	NULL
act	NULL
as	NULL
transcriptional	NULL
activa-tors	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
,	NULL
HTLV-I	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3137-3144	NULL
.	NULL

5	NULL
.	NULL

Bosselut	NULL
,	NULL
R.	NULL
,	NULL
F.	NULL
Lim	NULL
,	NULL
P.-C.	NULL
Romond	NULL
,	NULL
J.	NULL
Frampton	NULL
,	NULL
J.	NULL
N.	NULL
Brady	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1992	NULL
.	NULL

Myb	NULL
protein	NULL
binds	NULL
to	NULL
multiple	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
transactivates	NULL
LTR-mediated	NULL
expression	NULL
.	NULL

Virology	NULL
186:764-769	NULL
.	NULL

6	NULL
.	NULL

Brady	NULL
,	NULL
J.	NULL
,	NULL
K.-T.	NULL
Jeang	NULL
,	NULL
J.	NULL
Duvall	NULL
,	NULL
and	NULL
G.	NULL
Khoury	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
p40x-responsive	NULL
regulatory	NULL
sequences	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61	NULL
:	NULL
2175-2181	NULL
.	NULL

7	NULL
.	NULL

Demarchi	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
D'Agaro	NULL
,	NULL
A.	NULL
Falaschi	NULL
,	NULL
and	NULL
M.	NULL
Giacca	NULL
.	NULL

1992	NULL
.	NULL

Probing	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:2514-2518	NULL
.	NULL

8	NULL
.	NULL

Didier	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
J.	NULL
Schiffenbauer	NULL
,	NULL
S.	NULL
L.	NULL
Woulfe	NULL
,	NULL
M.	NULL
Zacheis	NULL
,	NULL
and	NULL
B.	NULL
D.	NULL
Schwartz	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
a	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
Y	NULL
box	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Â§5:7322-7326	NULL
.	NULL

9	NULL
.	NULL

Dittmer	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
D.	NULL
Gitlin	NULL
,	NULL
R.	NULL
L.	NULL
Reid	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
by	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
;	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
transcription	NULL
factor	NULL
Ets1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:0087-6095	NULL
.	NULL

10	NULL
.	NULL

Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
H.	NULL
Paskalis	NULL
,	NULL
D.	NULL
Kleinman-Ewing	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
,	NULL
1985	NULL
.	NULL

The	NULL
pX	NULL
protein	NULL
of	NULL
HTLV-1	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
its	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Science	NULL
229	NULL
:	NULL
675-679	NULL
.	NULL

11	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.-L.	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
T.	NULL
Yoshimura	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
indirect	NULL
association	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
fax	NULL
protein	NULL
with	NULL
DNA	NULL
results	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4525-4528	NULL
.	NULL

12	NULL
.	NULL

Gitlin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1991	NULL
.	NULL

Sequence-specific	NULL
interaction	NULL
of	NULL
the	NULL
Ets1	NULL
protein	NULL
with	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I.	NULL
J.	NULL
Virol	NULL
.	NULL

65:5513-5523	NULL
.	NULL

13	NULL
.	NULL

Goldsmith	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
M.	NULL
J.	NULL
Madden	NULL
,	NULL
C.	NULL
S.	NULL
Morrow	NULL
,	NULL
and	NULL
K.	NULL
H.	NULL
Cowan	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
Y-box	NULL
consensus	NULL
sequence	NULL
is	NULL
required	NULL
for	NULL
basal	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
multidrug	NULL
resistance	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:5856-5860	NULL
.	NULL

14	NULL
.	NULL

Grant	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Deeley	NULL
.	NULL

1993	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
chicken	NULL
YB-1	NULL
:	NULL
regulation	NULL
of	NULL
expression	NULL
in	NULL
the	NULL
liver	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
;	NULL
4186-4196	NULL
.	NULL

15	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
(	NULL
p40Â®	NULL
)	NULL
and	NULL
post-transcriptional	NULL
(	NULL
p27	NULL
)	NULL
regulators	NULL
are	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
and	NULL
replication	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3653-3657	NULL
.	NULL

16	NULL
.	NULL

Karlin	NULL
,	NULL
S.	NULL
1993	NULL
.	NULL

Unusual	NULL
charge	NULL
configurations	NULL
in	NULL
transcription	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
factors	NULL
of	NULL
the	NULL
basic	NULL
RNA	NULL
polymerase	NULL
II	NULL
initiation	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:5593-5597.	NULL
.	NULL

Kashanchi	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
P.	NULL
F.	NULL
Lindholm	NULL
,	NULL
M.	NULL
F.	NULL
Radonovich	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

Sequences	NULL
downstream	NULL
of	NULL
the	NULL
RNA	NULL
initiation	NULL
site	NULL
regulate	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
basal	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2894-2902.	NULL
.	NULL

Kim	NULL
,	NULL
Y.	NULL
K.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Lee	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
70-base-pair	NULL
cell	NULL
cycle	NULL
regulatory	NULL
unit	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
thymidine	NULL
kinase	NULL
gene	NULL
and	NULL
its	NULL
interaction	NULL
with	NULL
cellular	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2296-2302.	NULL
.	NULL

Li	NULL
,	NULL
X.-Y	NULL
.	NULL

,	NULL
R.	NULL
Mantovani	NULL
,	NULL
R.	NULL
Hooft	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
I.	NULL
Andre	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1992	NULL
.	NULL

Evolutionary	NULL
variation	NULL
of	NULL
the	NULL
CCAAT-binding	NULL
transcription	NULL
factor	NULL
NF-Y	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:1087-1091	NULL
.	NULL

Lindholm	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
F.	NULL
Kashanchi	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
the	NULL
human	NULL
retrovirus	NULL
HTLV-1	NULL
.	NULL

Semin	NULL
.	NULL

Virol	NULL
.	NULL

4:55-60	NULL
.	NULL

Lipson	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
S.-T.	NULL
Chen	NULL
,	NULL
J.	NULL
Koniecki	NULL
,	NULL
D.-H.	NULL
Ku	NULL
,	NULL
and	NULL
R.	NULL
Baserga	NULL
.	NULL

1989	NULL
.	NULL

S-phase-specific	NULL
regulation	NULL
by	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
human	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6848-6852	NULL
.	NULL

Mansour	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
T.	NULL
Grodzicker	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Downstream	NULL
sequences	NULL
affect	NULL
transcription	NULL
initiation	NULL
from	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:2684-2694	NULL
.	NULL

Marriott	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
P.	NULL
F.	NULL
Lindholm	NULL
,	NULL
K.	NULL
M.	NULL
Brown	NULL
,	NULL
S.	NULL
D.	NULL
Gitlin	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
M.	NULL
F.	NULL
Radonovich	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
36-kilodalton	NULL
cellular	NULL
transcription	NULL
factor	NULL
mediates	NULL
an	NULL
indirect	NULL
interaction	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia/lymphoma	NULL
virus	NULL
type	NULL
I	NULL
TAX	NULL
;	NULL
with	NULL
a	NULL
responsive	NULL
element	NULL
in	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:4192-4201	NULL
.	NULL

Montagne	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
I.	NULL
Crenon	NULL
,	NULL
G.	NULL
Lombard-Platet	NULL
,	NULL
L.	NULL
Gazzolo	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1990	NULL
.	NULL

Tax	NULL
!	NULL

induction	NULL
of	NULL
the	NULL
HTLV-1	NULL
21	NULL
bp	NULL
enhancer	NULL
requires	NULL
cooperation	NULL
between	NULL
two	NULL
cellular	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:957-964	NULL
.	NULL

Myers	NULL
,	NULL
G.	NULL
,	NULL
B.	NULL
Korber	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Berzofwsky	NULL
,	NULL
R.	NULL
F.	NULL
Smith	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

.	NULL

1992	NULL
.	NULL

Human	NULL
retroviruses	NULL
and	NULL
AIDS	NULL
.	NULL

A	NULL
compilation	NULL
and	NULL
analysis	NULL
of	NULL
nucleic	NULL
acid	NULL
and	NULL
amino	NULL
acid	NULL
sequences	NULL
.	NULL

Los	NULL
Alamos	NULL
National	NULL
Laboratory	NULL
,	NULL
Los	NULL
Alamos	NULL
,	NULL
N.	NULL
Mex	NULL
.	NULL

Nagata	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
endogenous	NULL
c-fos	NULL
proto-oncogene	NULL
expression	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40**	NULL
protein	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3220-3226	NULL
.	NULL

Nakamura	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
Y.	NULL
Hinuma	NULL
,	NULL
and	NULL
K.	NULL
Sugamora	NULL
.	NULL

1988	NULL
.	NULL

Functional	NULL
mapping	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
R	NULL
region	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
long	NULL
terminal	NULL
repeat	NULL
to	NULL
increase	NULL
gene	NULL
expression	NULL
.	NULL

Virus	NULL
Genes	NULL
2:147-155	NULL
.	NULL

Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
M.	NULL
H.	NULL
Matthews	NULL
,	NULL
J.	NULL
Yucel	NULL
,	NULL
L.	NULL
Walls	NULL
,	NULL
W.	NULL
T.	NULL
Golde	NULL
,	NULL
W.	NULL
S.	NULL
Dynan	NULL
,	NULL
and	NULL
W.	NULL
Wachsman	NULL
.	NULL

1990	NULL
.	NULL

Interaction	NULL
of	NULL
host	NULL
cell	NULL
proteins	NULL
with	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
transcriptional	NULL
control	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:8237-8242	NULL
.	NULL

Orchard	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Perkins	NULL
,	NULL
C.	NULL
Chapman	NULL
,	NULL
J.	NULL
Harris	NULL
,	NULL
V.	NULL
Emery	NULL
,	NULL
G.	NULL
Goodwin	NULL
,	NULL
D.	NULL
Latchman	NULL
,	NULL
and	NULL
M.	NULL
Collins	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
T-cell	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

NOTES	NULL
565	NULL
protein	NULL
which	NULL
recognizes	NULL
a	NULL
palindromic	NULL
sequence	NULL
in	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3234-3249	NULL
.	NULL

Ozer	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Faber	NULL
,	NULL
R.	NULL
Chalkley	NULL
,	NULL
and	NULL
L.	NULL
Sealy	NULL
.	NULL

1990	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
for	NULL
the	NULL
CCAAT	NULL
transcription	NULL
factor	NULL
EFIA	NULL
reveals	NULL
a	NULL
novel	NULL
structural	NULL
motif	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:22143-22152	NULL
.	NULL

Paskalis	NULL
,	NULL
H.	NULL
,	NULL
B.	NULL
K.	NULL
Felber	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1986.	NULL
cis-acting	NULL
sequences	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
constitute	NULL
a	NULL
conditional	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:6558-6562	NULL
.	NULL

Sabath	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
P.	NULL
L.	NULL
Podolin	NULL
,	NULL
P.	NULL
G.	NULL
Comber	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Prystowsky	NULL
.	NULL

1990.	NULL
cDNA	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
interleukin	NULL
2-induced	NULL
genes	NULL
in	NULL
a	NULL
cloned	NULL
T	NULL
helper	NULL
lymphocyte	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:12671-12678	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Hikikoshi	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
U5	NULL
sequence	NULL
is	NULL
a	NULL
cis-acting	NULL
repressive	NULL
element	NULL
for	NULL
genomic	NULL
RNA	NULL
expression	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Virology	NULL
176:81-86	NULL
.	NULL

Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Takano	NULL
,	NULL
T.	NULL
Teruuchi	NULL
,	NULL
and	NULL
M.	NULL
Miwa	NULL
.	NULL

1986	NULL
.	NULL

Requirement	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
a	NULL
21-nucleotide	NULL
sequence	NULL
in	NULL
the	NULL
U3	NULL
regions	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
long	NULL
terminal	NULL
repeats	NULL
for	NULL
trans-acting	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:8112-8116	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984.	NULL
transacting	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
lymphotropic	NULL
viruses	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Science	NULL
226:177-179	NULL
.	NULL

Spitkovsky	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
B.	NULL
Royer-Pokora	NULL
,	NULL
H.	NULL
Delius	NULL
,	NULL
F.	NULL
Kisselijov	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
and	NULL
H.-D.	NULL
Royer	NULL
.	NULL

1992	NULL
.	NULL

Tissue	NULL
restricted	NULL
expression	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
YB-1	NULL
gene	NULL
encoding	NULL
a	NULL
42kD	NULL
nuclear	NULL
CCAAT	NULL
binding	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:797-803	NULL
.	NULL

Stewart	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
M.	NULL
S.	NULL
McBride	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Winter	NULL
,	NULL
and	NULL
G.	NULL
Duester	NULL
.	NULL

1990	NULL
.	NULL

Promoters	NULL
for	NULL
the	NULL
human	NULL
alcohol	NULL
dehydrogenase	NULL
genes	NULL
ADH	NULL
!	NULL

1	NULL
,	NULL
ADH	NULL
2	NULL
,	NULL
and	NULL
ADH3	NULL
:	NULL
interaction	NULL
of	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
with	NULL
elements	NULL
flanking	NULL
the	NULL
ADH2	NULL
TATA	NULL
box	NULL
.	NULL

Gene	NULL
90:271-279	NULL
.	NULL

Tafuri	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
P.	NULL
Wolffe	NULL
.	NULL

1990	NULL
.	NULL

Xenopus	NULL
Y-box	NULL
transcription	NULL
factors	NULL
:	NULL
molecular	NULL
cloning	NULL
,	NULL
functional	NULL
analysis	NULL
,	NULL
and	NULL
developmental	NULL
regulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9028-9032	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
K.	NULL
L.	NULL
LaMarco	NULL
,	NULL
P.	NULL
F.	NULL
Johnson	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1988	NULL
.	NULL

In	NULL
situ	NULL
detection	NULL
of	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
specified	NULL
by	NULL
a	NULL
recombinant	NULL
bacteriophage	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:801-806	NULL
.	NULL

Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
S.	NULL
Tafuri	NULL
,	NULL
M.	NULL
Ranjan	NULL
,	NULL
and	NULL
M.	NULL
Familari	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
y-box	NULL
factors	NULL
:	NULL
a	NULL
family	NULL
of	NULL
nucleic	NULL
acid	NULL
binding	NULL
proteins	NULL
conserved	NULL
from	NULL
Escherichia	NULL
coli	NULL
to	NULL
man	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

4:290-298	NULL
.	NULL

Yan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
I.	NULL
Tamm	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
interferon	NULL
a/b	NULL
response	NULL
element	NULL
binding	NULL
factors	NULL
of	NULL
the	NULL
murine	NULL
(	NULL
2'-5	NULL
'	NULL
)	NULL
oligoadenylate	NULL
synthetase	NULL
ME-12	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:144-148	NULL
.	NULL

